Q2 2017 Holdings
Filed 2017-08-14 | 36 holdings | $70.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $41.2M | 1,482,600 | 58.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $12.3M | 794,969 | 17.4% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $9.7M | 805,000 | 13.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.0M | 185,472 | 7.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.2M | 23,300 | 1.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $831.0K | 10,425 | 1.2% |
| Alexion Pharmaceuticals, IncCall | COM | 015351909 | $78.2K | 569,500 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM | 46333X108 | $70.9K | 3,753,635 | 0.1% |
| Assembly Biosciences Inc | COM | 045396108 | $60.8K | 2,943,164 | 0.1% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $51.2K | 1,585,457 | 0.1% |
| Galapagos NV Spon ADR(GLPG) | SPONSORED ADR | 36315X101 | $44.3K | 578,505 | 0.1% |
| Gilead Sciences IncCall | COM | 375558903 | $38.0K | 500,000 | 0.1% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $22.6K | 2,568,119 | 0.0% |
| Kura Oncology Inc COM(KURA) | COM | 50127T109 | $18.9K | 2,033,622 | 0.0% |
| Tocagen Inc | COM | 888846102 | $18.1K | 1,502,373 | 0.0% |
| Editas Medicine Inc COM(EDIT) | COM | 28106W103 | $12.0K | 717,107 | 0.0% |
| Cascadian Therapeutics Inc | COM | 14740B606 | $11.1K | 3,000,000 | 0.0% |
| Vertex Pharmaceuticals IncCall | COM | 92532F900 | $9.1K | 60,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $8.2K | 2,537,026 | 0.0% |
| Atyr Pharma Inc(LIFEUSD) | COM | 002120103 | $7.8K | 2,292,659 | 0.0% |
| Ovascience Inc | COM | 69014Q101 | $5.5K | 3,512,332 | 0.0% |
| Kindred Biosciences Inc | COM | 494577109 | $4.7K | 544,880 | 0.0% |
| Tetraphase Pharmaceuticals Inc | COM | 88165N105 | $4.5K | 633,400 | 0.0% |
| Editas Medicine Inc COMCall | COM | 28106W903 | $4.3K | 255,000 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $3.7K | 3,709,144 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $3.4K | 742,835 | 0.0% |
| Nabriva Therapeutics | COM | G63637105 | $2.8K | 264,773 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $2.4K | 767,992 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $2.2K | 874,447 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $2.0K | 223,802 | 0.0% |
| Biohaven Pharmaceutical Hldg Co LTD(BHVN) | COM | G11196105 | $1.8K | 70,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $1.1K | 118,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $951 | 17,060 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $936 | 10,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $776 | 15,000 | 0.0% |
| Aratana Therapeutics Inc(PETXEUR) | COM | 03874P101 | $723 | 100,000 | 0.0% |